PMID- 16329133 OWN - NLM STAT- MEDLINE DCOM- 20060310 LR - 20181203 IS - 0008-543X (Print) IS - 0008-543X (Linking) VI - 106 IP - 1 DP - 2006 Jan 1 TI - Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma. PG - 146-55 AB - BACKGROUND: Lung cancer is a prevalent cancer with a poor prognosis. To develop a useful in vitro cell model, a cell line of lung squamous cell carcinoma (SCC-35) was established. METHODS: The SCC-35 cell was characterized by comparative genomic hybridization (CGH) and spectral karyotyping (SKY). Chromosome microdissection, fluorescence in situ hybridization (FISH), and Southern and Northern blots analyses were used to study target genes. RESULTS: Two amplicons were found at chromosomes 7p12 and 11q13. Amplification and overexpression of epidermal growth factor receptor (EGFR) at 7p12 and fibroblast growth factor 3 (FGF3) at 11q13 were found. To understand the correlation between these two genes in nonsmall cell lung carcinoma (NSCLC) more comprehensively, overexpression of FGF3 and EGFR was investigated by immunohistochemistry with a tissue microarray containing 406 NSCLC samples. Cytoplasmic overexpression of FGF3 and EGFR was detected in 61% and 69% NSCLC cases, respectively. More interestingly, a significant correlation between overexpression of FGF3 and EGFR was found in NSCLC. CONCLUSION: These results suggest that co-overexpression of FGF3 and EGFR may play an important role in the pathogenesis of lung carcinoma. CI - Copyright 2005 American Cancer Society. FAU - Tai, Amy L S AU - Tai AL AD - Department of Clinical Oncology, the University of Hong Kong, Hong Kong, China. FAU - Sham, Jonathan S T AU - Sham JS FAU - Xie, Dan AU - Xie D FAU - Fang, Yan AU - Fang Y FAU - Wu, Yi-Long AU - Wu YL FAU - Hu, Liang AU - Hu L FAU - Deng, Wen AU - Deng W FAU - Tsao, George S W AU - Tsao GS FAU - Qiao, Gui-Bin AU - Qiao GB FAU - Cheung, Annie L M AU - Cheung AL FAU - Guan, Xin-Yuan AU - Guan XY LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Cancer JT - Cancer JID - 0374236 RN - 0 (FGF3 protein, human) RN - 0 (Fibroblast Growth Factor 3) RN - EC 2.7.10.1 (ErbB Receptors) RN - EC 2.7.7.49 (Telomerase) SB - IM MH - Carcinoma, Non-Small-Cell Lung/genetics/*metabolism MH - Carcinoma, Squamous Cell/genetics/*metabolism MH - Cell Line, Tumor MH - Chromosomes, Human, Pair 11/genetics MH - Chromosomes, Human, Pair 7/genetics MH - ErbB Receptors/genetics/*metabolism MH - Fibroblast Growth Factor 3/genetics/*metabolism MH - Humans MH - Lung Neoplasms/genetics/*metabolism MH - Male MH - Middle Aged MH - Spectral Karyotyping MH - Telomerase/genetics/metabolism MH - Tissue Array Analysis EDAT- 2005/12/06 09:00 MHDA- 2006/03/11 09:00 CRDT- 2005/12/06 09:00 PHST- 2005/12/06 09:00 [pubmed] PHST- 2006/03/11 09:00 [medline] PHST- 2005/12/06 09:00 [entrez] AID - 10.1002/cncr.21581 [doi] PST - ppublish SO - Cancer. 2006 Jan 1;106(1):146-55. doi: 10.1002/cncr.21581.